NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.7700
+0.0300 (4.05%)
Aug 13, 2025, 9:30 AM EDT
ANSYS Market Cap
NurExone Biologic has a market cap or net worth of CAD 59.21 million as of August 13, 2025. Its market cap has increased by 37.74% in one year.
Market Cap
59.21M
Enterprise Value
58.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.77
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 59.21M, an increase of 76.82%. That is a compound annual growth rate of 19.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 59.21M | 34.70% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.28B |
| Curaleaf Holdings | 2.14B |
| Sienna Senior Living | 1.72B |
| dentalcorp Holdings | 1.63B |
| Trulieve Cannabis | 1.51B |
| WELL Health Technologies | 1.24B |
| Cronos Group | 1.22B |
| Extendicare | 1.10B |